Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lisa Bero

Showing results (41-50 of 206) with videos related to

Pageof 21
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|December 24, 2014
Measuring the effectiveness of scientific gatekeepingKyle Siler, Kirby Lee, Lisa Bero
Accountability in Research|April 3, 2020
A comparison of policy provisions for managing "financial" and "non-financial" interests across health-related research organizations: A qualitative content analysisQuinn Grundy, Sasha Mazzarello, Lisa Bero
BMJ (Clinical Research Ed.)|December 20, 2019
The SSSPIN study-spin in studies of spin: meta-research analysisLisa Bero, Kellia Chiu, Quinn Grundy
Australian Journal of General Practice|July 3, 2018
Interpreting evidence in general practice: Bias and conflicts of interestLisa Parker, Quinn Grundy, Lisa Bero
Journal of General Internal Medicine|September 19, 2019
Commercialization of User Data by Developers of Medicines-Related Apps: a Content AnalysisQuinn Grundy, Kellia Chiu, Lisa Bero
Trials|December 18, 2009
Association of trial registration with the results and conclusions of published trials of new oncology drugsNicolas Rasmussen, Kirby Lee, Lisa Bero
The Cochrane Database of Systematic Reviews|July 9, 2013
Interventions for tobacco use cessation in people in treatment for or recovery from substance abuseDorie Apollonio, Rose Philipps, Lisa Bero
The Cochrane Database of Systematic Reviews|November 24, 2016
Interventions for tobacco use cessation in people in treatment for or recovery from substance use disordersDorie Apollonio, Rose Philipps, Lisa Bero
Environmental Health Perspectives|March 4, 2014
Instruments for assessing risk of bias and other methodological criteria: Krauth et al. RespondDavid Krauth, Tracey J Woodruff, Lisa Bero
BMJ Open|February 21, 2019
Changes in the type and amount of spending disclosed by Australian pharmaceutical companies: an observational studyLisa Parker, Emily A Karanges, Lisa Bero
Pageof 21

Showing results (41-50 of 206) with videos related to

Sort By:
Pageof 21
Proceedings of the National Academy of Sciences of the United States of America|December 24, 2014
Measuring the effectiveness of scientific gatekeepingKyle Siler, Kirby Lee, Lisa Bero
Accountability in Research|April 3, 2020
A comparison of policy provisions for managing "financial" and "non-financial" interests across health-related research organizations: A qualitative content analysisQuinn Grundy, Sasha Mazzarello, Lisa Bero
BMJ (Clinical Research Ed.)|December 20, 2019
The SSSPIN study-spin in studies of spin: meta-research analysisLisa Bero, Kellia Chiu, Quinn Grundy
Australian Journal of General Practice|July 3, 2018
Interpreting evidence in general practice: Bias and conflicts of interestLisa Parker, Quinn Grundy, Lisa Bero
Journal of General Internal Medicine|September 19, 2019
Commercialization of User Data by Developers of Medicines-Related Apps: a Content AnalysisQuinn Grundy, Kellia Chiu, Lisa Bero
Trials|December 18, 2009
Association of trial registration with the results and conclusions of published trials of new oncology drugsNicolas Rasmussen, Kirby Lee, Lisa Bero
The Cochrane Database of Systematic Reviews|July 9, 2013
Interventions for tobacco use cessation in people in treatment for or recovery from substance abuseDorie Apollonio, Rose Philipps, Lisa Bero
The Cochrane Database of Systematic Reviews|November 24, 2016
Interventions for tobacco use cessation in people in treatment for or recovery from substance use disordersDorie Apollonio, Rose Philipps, Lisa Bero
Environmental Health Perspectives|March 4, 2014
Instruments for assessing risk of bias and other methodological criteria: Krauth et al. RespondDavid Krauth, Tracey J Woodruff, Lisa Bero
BMJ Open|February 21, 2019
Changes in the type and amount of spending disclosed by Australian pharmaceutical companies: an observational studyLisa Parker, Emily A Karanges, Lisa Bero
Pageof 21